Hantavirus Pulmonary Syndrome: Clinical Trials

5 trials for Hantavirus Pulmonary Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 not yet recruiting. 2 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Not yet recruiting 1
Phase 11Completed 1
Phase 21Completed 1

Follow Hantavirus Pulmonary Syndrome: new trials by email Literature Review of Hantavirus Pulmonary Syndrome trials Research Report on Hantavirus Pulmonary Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Natural History of Andes Virus Infection
Andes Hantavirus
Active not recruitingAssistance Publique - Hôpitaux de Paris152026-05-192026-07-14
Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Peripheral venous blood sample - Leishmaniasis, Leptospirosis
Not applicableNot yet recruitingUniversity Hospital, Montpellier1832025-03-032025-03-05
Andes Virus DNA Vaccine for the Prevention of Hantavirus Pulmonary Syndrome Using the PharmaJet Stratis(R) Needle-Free Injection Delivery Device
Andes virus DNA vaccine, Placebo - Hantavirus Pulmonary Infection, Immunisation
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)482019-02-192022-11-22
Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome
Methylprednisolone, Placebo - Hantavirus Infections
Phase 2CompletedUniversity of New Mexico662003-01-012014-12-24
A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome
Ribavirin - Hantavirus Pulmonary Syndrome
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)1302010-08-27

Narrower conditions

Brucellosis (1)  ·  Chikungunya Fever (1)  ·  Encephalitis, Tick-Borne (1)  ·  Hantavirus Infections (1)  ·  Hepatitis E (1)  ·  Leishmaniasis (1)  ·  Leptospirosis (1)  ·  Lyme Disease (1)  ·  Psittacosis (1)  ·  Q Fever (1)  ·  Rickettsia Infections (1)  ·  Tularemia (1)  ·  Zika Virus Infection (1)

Broader conditions

Bunyaviridae Infections (5)  ·  Infections (5)  ·  RNA Virus Infections (5)  ·  Respiration Disorders (5)  ·  Respiratory Insufficiency (5)  ·  Respiratory Tract Diseases (5)  ·  Virus Diseases (5)  ·  Hantavirus Infections (4)  ·  Alphavirus Infections (1)  ·  Arbovirus Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Borrelia Infections (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)

Interventions

Methylprednisolone (1)  ·  Ribavirin (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  University Hospital, Montpellier (1)  ·  University of New Mexico (1)

Countries

France (2)  ·  United States (2)  ·  Chile (1)

Top investigators

Pablo Vial, MD (1)

Results publications

PMID 23784924, PMID 37380156